Oxford BioMedica PLC buy melinda
Start price
22.09.10
/
50%
€3.00
Target price
22.03.11
€4.50
Performance (%)
-41.67%
End price
22.03.11
€1.75
Summary
This prediction ended on 22.03.11 with a price of €1.75. The BUY prediction by melinda for Oxford BioMedica PLC performed very badly with a performance of -41.67%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oxford BioMedica PLC | 19.048% | 19.048% | 108.333% | 107.469% |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
Comments by melinda for this prediction
In the thread Oxford BioMedica PLC diskutieren
Biopharma-
Oxford BioMedica ist ein biopharmazeutisches Unternehmen in der Entwicklung und Kommerzialisierung von innovativen Gen-basierter Medikamente spezialisiert
(Laufzeit überschritten)